{"id":"https://openalex.org/W2074994142","doi":"https://doi.org/10.1111/j.1360-0443.1992.tb01918.x","title":"Temazepam misuse in a group of injecting drug users","display_name":"Temazepam misuse in a group of injecting drug users","alternate_titles":[],"publication_year":1992,"publication_date":"1992-10-01","ids":{"openalex":"https://openalex.org/W2074994142","doi":"https://doi.org/10.1111/j.1360-0443.1992.tb01918.x","mag":"2074994142","pmid":"https://pubmed.ncbi.nlm.nih.gov/1422104"},"language":"en","primary_location":{"id":"doi:10.1111/j.1360-0443.1992.tb01918.x","doi":"https://doi.org/10.1111/j.1360-0443.1992.tb01918.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1360-0443.1992.tb01918.x","pdf_url":null,"source":{"id":"https://openalex.org/S4210197271","display_name":"British Journal of Addiction","issn_l":"0952-0481","issn":["0952-0481","2056-5178"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Addiction","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2074994142"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110052828","display_name":"Susan M. Ruben","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"SUSAN M. RUBEN","raw_affiliation_strings":["Liverpool Drug Dependency Clinic, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Liverpool Drug Dependency Clinic, UK","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110145886","display_name":"CLIVE L. MORRISON","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"CLIVE L. MORRISON","raw_affiliation_strings":["The Maryland Centre, 8 Maryland Street, Liverpool LI 9DE, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Maryland Centre, 8 Maryland Street, Liverpool LI 9DE, UK","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.9644,"has_fulltext":false,"cited_by_count":64,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.95381406,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"87","issue":"10","first_page":"1387","last_page":"1392"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.4077000021934509,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.4077000021934509,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.35179999470710754,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11860","display_name":"HIV, Drug Use, Sexual Risk","score":0.20309999585151672,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/temazepam","display_name":"temazepam","score":0.9599999785423279},{"id":"https://openalex.org/keywords/drug-abuse","display_name":"drug abuse","score":0.9070000052452087},{"id":"https://openalex.org/keywords/people-who-inject-drugs","display_name":"people who inject drugs","score":0.9819999933242798},{"id":"https://openalex.org/keywords/polysubstance-use","display_name":"polydrug use","score":0.6949999928474426},{"id":"https://openalex.org/keywords/superficial-venous-thrombosis","display_name":"superficial thrombophlebitis","score":0.953000009059906},{"id":"https://openalex.org/keywords/abscess","display_name":"abscess","score":0.9610000252723694},{"id":"https://openalex.org/keywords/deep-vein-thrombosis","display_name":"deep vein thrombosis","score":0.9509999752044678},{"id":"https://openalex.org/keywords/drug-supply-control","display_name":"drug supply control","score":0.5509999990463257},{"id":"https://openalex.org/keywords/prescriber-education","display_name":"prescriber education","score":0.5519999861717224},{"id":"https://openalex.org/keywords/general-practitioners","display_name":"general practitioners","score":0.9399999976158142}],"concepts":[{"id":"https://openalex.org/C2781006864","wikidata":"https://www.wikidata.org/wiki/Q414796","display_name":"Temazepam","level":4,"score":0.9840807914733887},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7227671146392822},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5812738537788391},{"id":"https://openalex.org/C2777363581","wikidata":"https://www.wikidata.org/wiki/Q15098235","display_name":"Harm","level":2,"score":0.4746723175048828},{"id":"https://openalex.org/C3018008698","wikidata":"https://www.wikidata.org/wiki/Q3184856","display_name":"Drug misuse","level":3,"score":0.45430949330329895},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.33988624811172485},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2922322452068329},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.11521083116531372},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.11247161030769348},{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.07057112455368042},{"id":"https://openalex.org/C77805123","wikidata":"https://www.wikidata.org/wiki/Q161272","display_name":"Social psychology","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002214","descriptor_name":"Capsules","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013693","descriptor_name":"Temazepam","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000635","qualifier_name":"transmission","is_major_topic":false},{"descriptor_ui":"D015819","descriptor_name":"Substance Abuse, Intravenous","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D015819","descriptor_name":"Substance Abuse, Intravenous","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1360-0443.1992.tb01918.x","doi":"https://doi.org/10.1111/j.1360-0443.1992.tb01918.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1360-0443.1992.tb01918.x","pdf_url":null,"source":{"id":"https://openalex.org/S4210197271","display_name":"British Journal of Addiction","issn_l":"0952-0481","issn":["0952-0481","2056-5178"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Addiction","raw_type":"journal-article"},{"id":"pmid:1422104","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1422104","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of addiction","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":13,"referenced_works":["https://openalex.org/W2006751065","https://openalex.org/W2019552829","https://openalex.org/W2036760921","https://openalex.org/W2040173795","https://openalex.org/W2044998256","https://openalex.org/W2046057665","https://openalex.org/W2086668721","https://openalex.org/W2091121625","https://openalex.org/W2146241892","https://openalex.org/W2163628592","https://openalex.org/W2421846671","https://openalex.org/W4239815796","https://openalex.org/W4249343027"],"related_works":["https://openalex.org/W2045146466","https://openalex.org/W2146186643","https://openalex.org/W2008214197","https://openalex.org/W2064559223","https://openalex.org/W1965658332","https://openalex.org/W4250894445","https://openalex.org/W2148711098","https://openalex.org/W2072274744","https://openalex.org/W2054352902","https://openalex.org/W2119809308"],"abstract_inverted_index":{"It":[0,97],"is":[1,45],"well":[2],"recognized":[3],"that":[4,34,87],"many":[5],"injecting":[6],"drug":[7,66,119,143,161],"users":[8,120],"are":[9,148],"poly-drug":[10],"users.":[11,162],"The":[12,43,125],"intravenous":[13],"use":[14],"of":[15,26,82,140,152],"Temazepam":[16,53,74,84,115,141,153],"has":[17],"become":[18,122],"popular":[19],"recently.":[20],"In":[21],"response":[22],"to":[23,41,60,64,70,99,121,142,160],"the":[24,28,72,88,92,138,149],"ease":[25],"misuse,":[27],"pharmaceutical":[29],"industry":[30],"produced":[31],"a":[32,46],"formulation":[33],"would":[35],"be":[36,100,134],"as":[37,39],"'resistant'":[38],"possible":[40],"injecting.":[42],"preparation":[44,94],"gel-filled":[47,62,93],"formulation,":[48],"one":[49],"proprietary":[50],"name":[51],"being":[52],"Gelthix.":[54],"General":[55,145],"Practitioners":[56],"have":[57],"been":[58],"encouraged":[59],"prescribe":[61],"capsules":[63],"potential":[65],"misusers":[67],"in":[68,103,158],"order":[69],"reduce":[71],"harm":[73],"can":[75,117],"cause":[76,118],"by":[77],"its":[78],"misuse.":[79],"This":[80],"study":[81,126],"23":[83],"injectors":[85],"shows":[86],"group":[89,127],"still":[90],"find":[91],"readily":[95],"injectable.":[96],"appears":[98],"more":[101,123],"problematic":[102],"causing":[104],"medical":[105],"complications":[106],"including":[107],"superficial":[108],"thrombophlebitis,":[109],"abscesses":[110],"and":[111,130],"deep":[112],"venous":[113],"thrombosis.":[114],"misuse":[116],"chaotic.":[124],"recognize":[128],"this":[129],"suggest":[131],"there":[132],"should":[133],"stricter":[135],"control":[136],"on":[137],"supply":[139],"dependents.":[144],"Practitioners,":[146],"who":[147],"main":[150],"source":[151],"prescribing,":[154],"require":[155],"additional":[156],"training":[157],"prescribing":[159]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2074994142","counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
